UC214

(S)-(−)-Warfarin

≥97% (HPLC)

• Synonym(e): S-(−)-3-Acetonybenzyl)-4-hydroxycoumarin, S-(−)-4-Hydroxy-3-(3-oxo-1-phenybutyl)-2H-1-benzopyran-2-one
• Empirische Formel (Hill-System): C₁₉H₁₆O₄
• CAS-Nummer: 5543-57-7
• Molekulargewicht: 308.33
• EG-Nummer: 226-907-3
• MDL-Nummer: MFCD00272381
• UNSPSC-Code: 12161501
• PubChem Substanz-ID: 24724650
• NACRES: NA.77

Eigenschaften

• Assay: ≥97% (HPLC)
• Form: solid
• Farbe: white to pale yellow
• mp (Schmelzpunkt): ≥170 °C
• Lagertemp.: 2-8°C
• SMILES String: [H][C@](CC(C)=O)(c1ccccc1)C2=C(O)c3ccccc3OC2=O
• InChI: 1S/C19H16O4/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22/h2-10,15,21H,11H2,1H3/t15-/m0/s1
• InChIKey: PJVWKTKQMONHTI-HNNXBMFYSA-N
• Angaben zum Gen: human ... CYP2C9(1559)

Beschreibung

Allgemeine Beschreibung

Warfarin is an antagonist of vitamin K. It is an oral coumarin anticoagulant.

Anwendung

(S)-(−)-Warfarin has been used in cell cultures.

Studies using (R)-(+)-warfarin have reported that it can upregulate hepatic CYP3A4 and CYP2C. It has also been used in HepG2 cells to study protein profiles.

Biochem./physiol. Wirkung

Warfarin is used to regulate and inhibit thromboembolic disorders. The CYP2C9 (cytochrome P450 family 2 subfamily C member 9) protein plays a major role in the inactivation of potent S-warfarin.

CYP2C9 substrate; anticoagulant.

Verpackung

Bottomless glass bottle. Contents are inside inserted fused cone.

Sicherheitshinweise

• Piktogramme: GHS06,GHS08,GHS09
• Signalwort: Danger
• H-Sätze: H300 + H310 + H330,H360D,H372,H411
• P-Sätze: P202 - P264 - P273 - P280 - P302 + P352 + P310 - P304 + P340 + P310
• Gefahreneinstufungen: Acute Tox. 1 Dermal - Acute Tox. 1 Inhalation - Acute Tox. 2 Oral - Aquatic Chronic 2 - Repr. 1A - STOT RE 1
• Zielorgane: Blood
• Lagerklassenschlüssel: 6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable